Browsing: DecentralizationTransform

According to the U.S. Food and Drug Administration (FDA), there are more than 30 million people living with a rare disease in the country, around half of whom are children. An analysis by Allucent indicated that in 2025, rare disease studies accounted for more than a quarter of clinical trial activity